View in EDS

DLL3-Targeted Strategies in Advanced Prostate Cancer: Current Evidence and Future Perspectives.

Saved in:
Bibliographic Details
Title: DLL3-Targeted Strategies in Advanced Prostate Cancer: Current Evidence and Future Perspectives.
Authors: Pecoraro G; Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland.; Institute of Oncology Research (IOR), Bellinzona, Switzerland.; Clinical and Translational Oncology, Scuola Superiore Meridionale, Via Mezzocannone 4, 80134, Naples, Italy., De Giorgi A; Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland.; Medical Oncology Department, Turin University, Turin, Italy., Montelatici G; Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland.; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Salfi G; Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland., Lin HM; Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland., Turco F; Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland., Taha T; The Institute of Cancer Research, London, UK.; The Royal Marsden NHS Foundation Trust, London, UK., Beltran H; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., de Bono J; The Institute of Cancer Research, London, UK.; The Royal Marsden NHS Foundation Trust, London, UK.; Division of Clinical Studies, The Institute of Cancer Research, London, UK., Aggarwal RR; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA., von Amsberg G; University Cancer Center Hamburg and Martini-Klinik, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany., Joerger M; Department of Medical Oncology and Hematology, Health Ostschweiz (HOCH), St Gallen, Switzerland., Imbimbo M; Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland., Colombo I; Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland., Gillessen S; Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland., Pedrani M; Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland. martino.pedrani@eoc.ch.
Source: Drugs [Drugs] 2026 Jul 29. Date of Electronic Publication: 2026 Jul 29.
Publication Type: Journal Article; Review
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 7600076 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1950 (Electronic) Linking ISSN: 00126667 NLM ISO Abbreviation: Drugs Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42527846
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: DLL3-Targeted Strategies in Advanced Prostate Cancer: Current Evidence and Future Perspectives.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Pecoraro+G%22">Pecoraro G</searchLink>; Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland.; Institute of Oncology Research (IOR), Bellinzona, Switzerland.; Clinical and Translational Oncology, Scuola Superiore Meridionale, Via Mezzocannone 4, 80134, Naples, Italy.<br /><searchLink fieldCode="AU" term="%22De+Giorgi+A%22">De Giorgi A</searchLink>; Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland.; Medical Oncology Department, Turin University, Turin, Italy.<br /><searchLink fieldCode="AU" term="%22Montelatici+G%22">Montelatici G</searchLink>; Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland.; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Salfi+G%22">Salfi G</searchLink>; Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Lin+HM%22">Lin HM</searchLink>; Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Turco+F%22">Turco F</searchLink>; Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Taha+T%22">Taha T</searchLink>; The Institute of Cancer Research, London, UK.; The Royal Marsden NHS Foundation Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Beltran+H%22">Beltran H</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22de+Bono+J%22">de Bono J</searchLink>; The Institute of Cancer Research, London, UK.; The Royal Marsden NHS Foundation Trust, London, UK.; Division of Clinical Studies, The Institute of Cancer Research, London, UK.<br /><searchLink fieldCode="AU" term="%22Aggarwal+RR%22">Aggarwal RR</searchLink>; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22von+Amsberg+G%22">von Amsberg G</searchLink>; University Cancer Center Hamburg and Martini-Klinik, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Joerger+M%22">Joerger M</searchLink>; Department of Medical Oncology and Hematology, Health Ostschweiz (HOCH), St Gallen, Switzerland.<br /><searchLink fieldCode="AU" term="%22Imbimbo+M%22">Imbimbo M</searchLink>; Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Colombo+I%22">Colombo I</searchLink>; Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Gillessen+S%22">Gillessen S</searchLink>; Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland.<br /><searchLink fieldCode="AU" term="%22Pedrani+M%22">Pedrani M</searchLink>; Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland. martino.pedrani@eoc.ch.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227600076%22">Drugs</searchLink> [Drugs] 2026 Jul 29. <i>Date of Electronic Publication: </i>2026 Jul 29.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>7600076 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1950 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200126667%22">00126667 </searchLink><i>NLM ISO Abbreviation: </i>Drugs <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42527846
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40265-026-02355-5
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: DLL3-Targeted Strategies in Advanced Prostate Cancer: Current Evidence and Future Perspectives.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Pecoraro G
      – PersonEntity:
          Name:
            NameFull: De Giorgi A
      – PersonEntity:
          Name:
            NameFull: Montelatici G
      – PersonEntity:
          Name:
            NameFull: Salfi G
      – PersonEntity:
          Name:
            NameFull: Lin HM
      – PersonEntity:
          Name:
            NameFull: Turco F
      – PersonEntity:
          Name:
            NameFull: Taha T
      – PersonEntity:
          Name:
            NameFull: Beltran H
      – PersonEntity:
          Name:
            NameFull: de Bono J
      – PersonEntity:
          Name:
            NameFull: Aggarwal RR
      – PersonEntity:
          Name:
            NameFull: von Amsberg G
      – PersonEntity:
          Name:
            NameFull: Joerger M
      – PersonEntity:
          Name:
            NameFull: Imbimbo M
      – PersonEntity:
          Name:
            NameFull: Colombo I
      – PersonEntity:
          Name:
            NameFull: Gillessen S
      – PersonEntity:
          Name:
            NameFull: Pedrani M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 29
              M: 07
              Text: 2026 Jul 29
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1179-1950
          Titles:
            – TitleFull: Drugs
              Type: main
ResultId 1